You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 10,206,882


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,206,882
Title:Stable digestive enzyme compositions
Abstract: Compositions of the present invention, comprising at least one digestive enzyme (e.g., pancrelipase) are useful for treating or preventing disorders associated with digestive enzyme deficiencies. The compositions of the present invention can comprise a plurality of coated particles, each of which is comprised of a core coated with an enteric coating comprising at least one enteric polymer and 4-10% of at least one alkalinizing agent, or have moisture contents of about 3% or less, water activities of about 0.6 or less, or exhibit a loss of activity of no more than about 15% after six months of accelerated stability testing.
Inventor(s): Ortenzi; Giovanni (Monza, IT), Marconi; Marco (Cinisello Balsamo, IT), Mapelli; Luigi (Milan, IT)
Assignee: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (Dublin, IE)
Application Number:14/043,923
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,206,882

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 10,206,882, using it as a case study to explain the key concepts and processes involved in patent claims and scope.

What is a Patent?

A patent is a form of intellectual property that grants the owner the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[2].

Determining Inventorship

Before diving into the patent itself, it's essential to understand who is entitled to be listed as an inventor. U.S. patent law stipulates that only the "true and only" inventors should be listed on a patent application. This involves identifying those who conceived the idea and reduced it to practice[2].

Patent Search and Research

To analyze a patent, one must first locate it through a patent search. The USPTO provides several tools for this, including the Public Search Facility and online databases like the Global Dossier, which allows users to access file histories and related applications from participating IP offices[1].

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process[3].

Patent Scope

Patent scope refers to the breadth of protection granted by the patent. It is a critical aspect in debates over patent quality, as overly broad patents can lead to increased licensing and litigation costs. Metrics such as independent claim length and count help in assessing the scope[3].

The Examination Process

The USPTO's examination process involves several stages, including initial review, potential rejections, and continuations. Continuations allow applicants to file new applications related to the original, which can complicate the calculation of allowance rates[4].

Allowance Rates

There are several measures of patent allowance rates:

  • First-action allowance rate: The proportion of applications allowed without further examination.
  • Progenitor allowance rate: The proportion of original applications allowed without any continuation procedure.
  • Family allowance rate: The proportion of original applications that produce at least one patent, including outcomes of continuation applications[4].

Case Study: United States Patent 10,206,882

Patent Title and Abstract

To begin, one would look at the title and abstract of the patent to understand the general nature of the invention. The title provides a brief description, while the abstract gives a more detailed overview of the invention and its purpose.

Claims Analysis

  • Independent Claims: Identify the independent claims to understand the core of the invention. These claims define what is novel and non-obvious about the invention.
  • Dependent Claims: Analyze the dependent claims to see how they further limit and specify the invention.

Description and Drawings

The detailed description and drawings provide a comprehensive understanding of the invention. This section explains how the invention works, its components, and any variations or embodiments.

Prior Art and Citations

Review the prior art cited in the patent to understand the existing technology and how the current invention improves upon it. This helps in assessing the novelty and non-obviousness of the invention.

Legal and Practical Considerations

Correct Inventorship

Ensure that the inventors listed on the patent are the true and only inventors. Errors in inventorship can lead to the patent being invalid and unenforceable if there was deceptive intent[2].

Litigation and Enforcement

Understanding the scope and claims is crucial for litigation and enforcement. A patent with clear and narrow claims is generally easier to enforce than one with broad and vague claims[3].

Small Claims Patent Court

In the context of patent litigation, there has been discussion about establishing a small claims patent court to handle smaller-scale disputes more efficiently. This would involve simpler procedures and lower costs, making it more accessible for smaller entities[5].

Key Takeaways

  • Patent Claims: The claims define the scope of the invention and are crucial for understanding what is protected.
  • Patent Scope: Metrics like independent claim length and count help in assessing the breadth of protection.
  • Examination Process: Understanding the various stages of the examination process, including continuations, is vital for navigating the patent system.
  • Inventorship: Correctly identifying the true and only inventors is essential for the validity and enforceability of the patent.
  • Litigation: Clear and narrow claims are generally easier to enforce than broad and vague ones.

FAQs

Q: What is the importance of independent claims in a patent?

A: Independent claims define the core of the invention and are essential for understanding what is protected by the patent.

Q: How do continuations affect the patent examination process?

A: Continuations allow applicants to file new applications related to the original, which can complicate the calculation of allowance rates but provide additional opportunities for patent protection.

Q: Why is correct inventorship crucial for a patent?

A: Correct inventorship ensures the patent's validity and enforceability. Errors with deceptive intent can render the patent unenforceable.

Q: What is the role of the Global Dossier in patent research?

A: The Global Dossier provides access to file histories and related applications from participating IP offices, helping users to see the patent family and related data.

Q: What is the proposed benefit of a small claims patent court?

A: A small claims patent court would provide a simpler and more cost-effective way to handle smaller-scale patent disputes, making it more accessible for smaller entities.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Determining Inventorship for US Patent Applications: https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  3. Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe

Details for Patent 10,206,882

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. COTAZYM pancrelipase Capsule, Delayed Release 020580 December 09, 1996 10,206,882 2027-02-20
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 April 30, 2009 10,206,882 2027-02-20
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 June 10, 2011 10,206,882 2027-02-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.